[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 206, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Erick J. Lucera C.F.A., CPA", "age": 56, "title": "CFO, Principal Financial Officer & Principal Accounting Officer and Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 58, "title": "Chief Technical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ranjan  Batra Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 12.55, "open": 12.56, "dayLow": 12.56, "dayHigh": 13.11, "regularMarketPreviousClose": 12.55, "regularMarketOpen": 12.56, "regularMarketDayLow": 12.56, "regularMarketDayHigh": 13.11, "payoutRatio": 0.0, "beta": 1.083, "forwardPE": -4.132911, "volume": 1256470, "regularMarketVolume": 1256470, "averageVolume": 2758284, "averageVolume10days": 2426520, "averageDailyVolume10Day": 2426520, "bid": 9.39, "ask": 16.08, "bidSize": 2, "askSize": 2, "marketCap": 1857964544, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 35.9, "allTimeHigh": 47.45, "allTimeLow": 4.3, "fiftyDayAverage": 12.3365, "twoHundredDayAverage": 12.88645, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1295116416, "profitMargins": 0.0, "floatShares": 122631344, "sharesOutstanding": 142263740, "sharesShort": 15303535, "sharesShortPriorMonth": 17141207, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.1076, "heldPercentInsiders": 0.00491, "heldPercentInstitutions": 0.94641995, "shortRatio": 6.78, "shortPercentOfFloat": 0.1201, "impliedSharesOutstanding": 149661454, "bookValue": 4.998, "priceToBook": 2.6130452, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -412886016, "trailingEps": -3.88, "forwardEps": -3.16, "enterpriseToEbitda": -2.95, "52WeekChange": -0.5877525, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 13.06, "targetHighPrice": 50.0, "targetLowPrice": 9.0, "targetMeanPrice": 34.4375, "targetMedianPrice": 37.0, "recommendationMean": 1.5625, "recommendationKey": "buy", "numberOfAnalystOpinions": 16, "totalCash": 683924992, "totalCashPerShare": 4.807, "ebitda": -439036992, "totalDebt": 121077000, "quickRatio": 16.491, "currentRatio": 16.829, "debtToEquity": 21.188, "returnOnAssets": -0.35446998, "returnOnEquity": -0.61320996, "freeCashflow": -222398000, "operatingCashflow": -359560000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1759533093, "regularMarketTime": 1759521600, "shortName": "Dyne Therapeutics, Inc.", "longName": "Dyne Therapeutics, Inc.", "regularMarketChangePercent": 4.06375, "regularMarketPrice": 13.06, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2758284, "fiftyTwoWeekLowChange": 6.7000003, "fiftyTwoWeekLowChangePercent": 1.0534592, "fiftyTwoWeekRange": "6.36 - 35.9", "fiftyTwoWeekHighChange": -22.84, "fiftyTwoWeekHighChangePercent": -0.6362117, "fiftyTwoWeekChangePercent": -58.775253, "earningsTimestampStart": 1761681600, "earningsTimestampEnd": 1761681600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.88, "epsForward": -3.16, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "postMarketChangePercent": 1.45482, "postMarketPrice": 13.25, "postMarketChange": 0.19, "regularMarketChange": 0.51, "regularMarketDayRange": "12.56 - 13.11", "epsCurrentYear": -3.65627, "priceEpsCurrentYear": -3.5719464, "fiftyDayAverageChange": 0.72350025, "fiftyDayAverageChangePercent": 0.058647122, "twoHundredDayAverageChange": 0.1735506, "twoHundredDayAverageChangePercent": 0.013467682, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.6 - Buy", "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]